Unique ID issued by UMIN | UMIN000032122 |
---|---|
Receipt number | R000036648 |
Scientific Title | Suppressive effect of Supplement on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study- |
Date of disclosure of the study information | 2018/04/05 |
Last modified on | 2018/05/22 13:48:02 |
Suppressive effect of Supplement on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study-
Suppressive effect of Supplement on the postprandial blood glucose level
Suppressive effect of Supplement on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study-
Suppressive effect of Supplement on the postprandial blood glucose level
Japan |
Healthy subjects
Adult |
Others
NO
To investigate the effect of test food on the postprandial blood glucose level of subjects
Efficacy
AUC for postprandial blood glucose level
・AUC for insulin level
・Postprandial blood glucose levels and insulin levels of 30, 60, 90, and 120 minutes after sucrose ingestion
・Cmax for blood glucose level
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Intake of test food, and then ingestion of placebo after wash out period
Intake of placebo, and then ingestion of test food after wash out period
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Males and females 20 to 64 years of age
2)Subjects whose fasting blood glucose levels are less than 126 mg/dL.
3)Subjects whose postprandial blood glucose levels on 120 minutes after 75g sucrose ingestion are less than 200 mg/dL.
1)Subjects who have serious medical history and history of surgical resection of the gastrointestinal tract excluding appendectomy
2)Subjects whose HbA1c(NGSP) are more than 6.5%
3) Subjects who routinely use medicine, supplements, FOSHU, and/or health food which affect to result of the study.
4) Subjects who have allergy to test food and/or high fat meal and have diarrhea.
5) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
6) Heavy user of alcohol or excessive smokers
7) Subjects who are judged inappropriate for participation in this study by the investigator
40
1st name | |
Middle name | |
Last name | Kazuhiko Takano |
Medical Corporation Hokubukai Utsukushigaoka Hospital
clinical pharmacology center
61-1 Sin-ei, Kiyota-ku, Sapporo, Hokkaido 004-0839, Japan
011-882-0111
takano@ughp-cpc.jp
1st name | |
Middle name | |
Last name | Masaya Tsubokawa |
FANCL Corporation
Research Institute
12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan
045-820-3569
tsubokawa_masaya@fancl.co.jp
FANCL Corporation
FANCL Corporation
Profit organization
NO
医療法人北武会美しが丘病院
2018 | Year | 04 | Month | 05 | Day |
Unpublished
Completed
2018 | Year | 03 | Month | 09 | Day |
2018 | Year | 04 | Month | 02 | Day |
2018 | Year | 04 | Month | 05 | Day |
2018 | Year | 05 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036648
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |